Skip to main content
Caplight Logo









Myosana Therapeutics

Myosana Therapeutics

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://www.myosanatherapeutics.com/

Last Round

Crowdfunding

Nov 13, 2025

Est. Valuation

$27.38M

Total Funding Raised

$6.35M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Myosana Therapeutics is a biotechnology company that develops a muscle-specific non-viral gene therapy platform for the treatment of neuromuscular and cardiac diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapygene deliverynon-viral deliveryDMDDuchenne muscular dystrophyneuromuscular diseasegenetic medicinebiotechX-linked myotubular myopathyMTMdrug delivery platformrare disease therapyadeno-associated virusAAVgenetic engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Myosana Therapeutics Comparables

Compare Myosana Therapeutics with similar companies based on industry and business-model similarity.

Myosana Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Spot Biosystems
88%
Kinea Bio, Inc.
81%
SonoThera
78%

Myosana Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingNov 13, 2025
SeedJan 25, 2023
GrantAug 26, 2021
SeedApr 22, 2020

Myosana Therapeutics Investors

Notable investors and investment history

Myosana Therapeutics investors
InvestorRounds
CureDuchenne VenturesSeed, Crowdfunding
Parent Project Muscular DystrophyGrant, Seed, Crowdfunding
Muscular Dystrophy AssociationSeed, Crowdfunding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 150% MoM.

  • May 13, 2026

    Monthly visitors increased 37% MoM.

Myosana Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Myosana Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Myosana Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range3
Year Founded2018
Last FundingNov 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?